Advertisement
U.S. markets closed
S&P Futures
6,042.25 +4.00 (+0.07%) Dow Futures
45,004.00 +53.00 (+0.12%) Nasdaq Futures
20,994.50 +1.00 (+0.00%) Russell 2000 Futures
2,439.00 +6.60 (+0.27%) Crude Oil
68.64 -0.13 (-0.19%) Gold
2,633.50 +12.20 (+0.47%)
China SXT Pharmaceuticals, Inc. (SXTC)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Follow
At close: 04:00PM EST
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 1.60M |
| Enterprise Value | -7.82M |
| Trailing P/E | 12.51 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.18 |
| Price/Book (mrq) | 0.12 |
| Enterprise Value/Revenue | 0.41 |
| Enterprise Value/EBITDA | -0.36 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.16 |
| 52-Week Change 3 | -78.06% |
| S&P500 52-Week Change 3 | 31.57% |
| 52 Week High 3 | 6.3900 |
| 52 Week Low 3 | 0.3710 |
| 50-Day Moving Average 3 | 0.5708 |
| 200-Day Moving Average 3 | 1.0847 |
Share Statistics
| Avg Vol (3 month) 3 | 604.56k |
| Avg Vol (10 day) 3 | 106.98k |
| Shares Outstanding 5 | 4.06M |
| Implied Shares Outstanding 6 | 4.06M |
| Float 8 | 3.07M |
| % Held by Insiders 1 | 16.94% |
| % Held by Institutions 1 | 1.35% |
| Shares Short (Oct 31, 2024) 4 | 105.3k |
| Short Ratio (Oct 31, 2024) 4 | 0.22 |
| Short % of Float (Oct 31, 2024) 4 | 2.68% |
| Short % of Shares Outstanding (Oct 31, 2024) 4 | 2.59% |
| Shares Short (prior month Sep 30, 2024) 4 | 251.56k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:25 |
| Last Split Date 3 | Oct 05, 2023 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Mar 31, 2024 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | -160.67% |
| Operating Margin (ttm) | 733.81% |
Management Effectiveness
| Return on Assets (ttm) | -4.97% |
| Return on Equity (ttm) | -21.65% |
Income Statement
| Revenue (ttm) | 1.93M |
| Revenue Per Share (ttm) | 2.22 |
| Quarterly Revenue Growth (yoy) | 29.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -1.89M |
| Net Income Avi to Common (ttm) | -3.1M |
| Diluted EPS (ttm) | -3.5700 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 12.07M |
| Total Cash Per Share (mrq) | 3.47 |
| Total Debt (mrq) | 3.7M |
| Total Debt/Equity (mrq) | 26.52% |
| Current Ratio (mrq) | 1.60 |
| Book Value Per Share (mrq) | 6.28 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1.93M |
| Levered Free Cash Flow (ttm) | -1.22M |
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.